The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 26, 2019

Filed:

Jul. 28, 2014
Applicant:

Circuit Therapeutics, Inc., Menlo Park, CA (US);

Inventors:

David C. Lundmark, Los Altos, CA (US);

Karl Deisseroth, Stanford, CA (US);

Fred Moll, San Francisco, CA (US);

Dan Andersen, Menlo Park, CA (US);

Alexander K. Arrow, Lake Forest, CA (US);

Assignee:

Circuit Therapeutics, Inc., Menlo Park, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61B 5/06 (2006.01); A61N 5/06 (2006.01); A61N 1/05 (2006.01); A61N 1/36 (2006.01); A61K 38/16 (2006.01); A61K 48/00 (2006.01); A61K 41/00 (2006.01); A61M 25/01 (2006.01); A61M 37/00 (2006.01); A61K 38/17 (2006.01); A61B 17/00 (2006.01); A61B 17/34 (2006.01); A61M 5/142 (2006.01); A61M 5/20 (2006.01); A61N 5/067 (2006.01);
U.S. Cl.
CPC ...
A61N 5/0601 (2013.01); A61B 17/00234 (2013.01); A61B 17/3403 (2013.01); A61K 38/16 (2013.01); A61K 38/164 (2013.01); A61K 38/168 (2013.01); A61K 38/177 (2013.01); A61K 41/00 (2013.01); A61K 41/0057 (2013.01); A61K 48/00 (2013.01); A61K 48/0075 (2013.01); A61M 5/142 (2013.01); A61M 5/20 (2013.01); A61M 25/0105 (2013.01); A61M 25/0147 (2013.01); A61M 37/0015 (2013.01); A61N 1/0551 (2013.01); A61N 1/3605 (2013.01); A61N 1/36053 (2013.01); A61N 5/062 (2013.01); A61N 5/0622 (2013.01); A61B 2017/3413 (2013.01); A61M 2037/0023 (2013.01); A61M 2037/0061 (2013.01); A61M 2205/3576 (2013.01); A61M 2205/50 (2013.01); A61N 2005/063 (2013.01); A61N 2005/067 (2013.01); A61N 2005/0612 (2013.01); A61N 2005/0626 (2013.01); A61N 2005/0627 (2013.01); A61N 2005/0631 (2013.01); A61N 2005/0643 (2013.01); A61N 2005/0651 (2013.01); A61N 2005/0653 (2013.01); A61N 2005/0665 (2013.01);
Abstract

Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.


Find Patent Forward Citations

Loading…